EyePoint's major customers
Ani Pharmaceuticals accounted for 55% of EyePoint's revenue in FY 2025, down from 94% a year earlier.
Get an email when EyePoint's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Major customers of EyePoint
Customers that EyePoint named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Ani PharmaceuticalsANIP | 55% | ▼ from 94% | 3 years | FY 2025 · filed 5 Mar 2026 |
| SWK Funding | 40% | new | 1 year | FY 2025 · filed 5 Mar 2026 |
Formerly disclosed
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| PfizerPFE | 74% | last FY 2017 | 2 years | FY 2017 · filed 18 Sept 2018 |
| Alimera Sciences | 73% | last FY 2023 | 5 years | FY 2023 · filed 8 Mar 2024 |
| Third Party Logistics Provider | 56% | last FY 2019 | 1 year | FY 2019 · filed 12 Mar 2021 |
| ASD Specialty Healthcare | 51% | last FY 2022 | 4 years | FY 2022 · filed 8 Mar 2024 |
| Mckesson Specialty Care Distribution | 40% | last FY 2022 | 3 years | FY 2022 · filed 8 Mar 2024 |
| Bausch And LombBLCO | 35% | last FY 2018 | 6 years | FY 2018 · filed 18 Sept 2018 |
| Ocumension Therapeutics | 33% | last FY 2020 | 1 year | FY 2020 · filed 14 Mar 2022 |
| Alimera | 24% | last FY 2018 | 3 years | FY 2018 · filed 18 Sept 2018 |
| Besse Medical | 17% | last FY 2023 | 1 year | FY 2023 · filed 6 Mar 2025 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API